about
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus.Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsUsing virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus.Novel surface markers directed against adult human gallbladderTreg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus.Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma.Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming.Is a β cell a β cell?Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication.Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer.Reprogramming human gallbladder cells into insulin-producing β-like cells.Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideOncolytic immunovirotherapy for melanoma using vesicular stomatitis virus.Efficient generation of pancreatic β-like cells from the mouse gallbladder.Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
P50
Q33832148-D31584AB-23A7-4610-AC91-8CDF7EC32CF6Q33936327-1670FF9F-69C4-4183-8E0E-78AD96260C15Q34198856-24E39B1D-44D3-45B8-9671-8A6DE7FC631EQ35575688-BDED14B2-8D13-41F0-B423-30F4092364C7Q35894100-55A76C63-338F-4577-86E6-A6E60B2FE427Q37311960-1BE3C1FA-668B-409D-8A77-B8CC06D56FD4Q37602550-4D9C9555-82F0-472D-A189-76DBD8CA0CD3Q37613069-8F4953D3-3BB9-45DC-92BD-799AB71D5C9BQ39093694-CB83F901-A46C-48F3-993C-180201271F4CQ39840716-71E46FDA-D45F-4324-A4A4-A17E3ABBC923Q39933904-A636552C-41D0-4312-83E9-A4547BD2E2BEQ41432895-E15AF4EA-743E-4BF4-885E-ED2967849B88Q42157100-3CCB80AF-E8B5-4192-9ACB-C1543F6C00ACQ43599369-EAA481B1-4261-4BAD-AE00-B34024602760Q50478004-C852E74C-2D75-49C9-BAC7-F8AC46A0F658Q80162686-E77FB5DC-CEBE-4601-B5C3-276A3B67283F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Feorillo Galivo
@ast
Feorillo Galivo
@en
Feorillo Galivo
@es
Feorillo Galivo
@nl
Feorillo Galivo
@sl
type
label
Feorillo Galivo
@ast
Feorillo Galivo
@en
Feorillo Galivo
@es
Feorillo Galivo
@nl
Feorillo Galivo
@sl
prefLabel
Feorillo Galivo
@ast
Feorillo Galivo
@en
Feorillo Galivo
@es
Feorillo Galivo
@nl
Feorillo Galivo
@sl
P106
P1153
16199645300
P21
P31
P496
0000-0002-0553-922X